Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Net Income towards Common Stockholders: 2016-2025

Historic Net Income towards Common Stockholders for Anaptysbio (ANAB) over the last 10 years, with Sep 2025 value amounting to $15.1 million.

  • Anaptysbio's Net Income towards Common Stockholders rose 146.00% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year increase of 48.91%. This contributed to the annual value of -$145.2 million for FY2024, which is 11.24% up from last year.
  • Latest data reveals that Anaptysbio reported Net Income towards Common Stockholders of $15.1 million as of Q3 2025, which was up 139.12% from -$38.6 million recorded in Q2 2025.
  • Over the past 5 years, Anaptysbio's Net Income towards Common Stockholders peaked at $15.1 million during Q3 2025, and registered a low of -$46.7 million during Q2 2024.
  • For the 3-year period, Anaptysbio's Net Income towards Common Stockholders averaged around -$33.8 million, with its median value being -$39.3 million (2025).
  • As far as peak fluctuations go, Anaptysbio's Net Income towards Common Stockholders crashed by 6,121.91% in 2022, and later surged by 146.00% in 2025.
  • Over the past 5 years, Anaptysbio's Net Income towards Common Stockholders (Quarterly) stood at -$31.1 million in 2021, then rose by 28.80% to -$22.1 million in 2022, then tumbled by 90.71% to -$42.2 million in 2023, then surged by 48.39% to -$21.8 million in 2024, then spiked by 146.00% to $15.1 million in 2025.
  • Its Net Income towards Common Stockholders was $15.1 million in Q3 2025, compared to -$38.6 million in Q2 2025 and -$39.3 million in Q1 2025.